Polyunsaturated Fatty Acids: Conversion to Lipid Mediators, Roles in Inflammatory Diseases and Dietary Sources

Area of Science:

• Biochemistry
• Nutrition
• Immunology

Background:

• Polyunsaturated fatty acids (PUFAs), including essential fatty acids (EFAs) like linoleic and α-linolenic acid, are vital dietary components for mammals.
• PUFAs are metabolized into 20- and 22-carbon fatty acids, forming lipid mediators that influence inflammatory processes.
• Lipid mediators derived from n-3 PUFAs generally exhibit anti-inflammatory or neutral effects, while those from n-6 PUFAs are typically pro-inflammatory.

Purpose of the Study:

• To review the metabolic conversion of PUFAs into various lipid mediators.
• To outline the biological roles and molecular mechanisms of these mediators in inflammatory diseases.
• To detail natural sources of PUFAs and discuss strategies for increasing their production.

Main Methods:

• Literature review of PUFA metabolism and function.
• Analysis of lipid mediator pathways, including eicosanoids, docosanoids, specialized pro-resolving mediators (SPMs), and isoprostanes.
• Examination of natural PUFA sources and biotechnological approaches for enhanced production.

Main Results:

• PUFAs are precursors to diverse lipid mediators, including SPMs that actively resolve inflammation.
• Isoprostanes, generated via free radical reactions, also possess potent anti-inflammatory properties.
• Mammals have limited capacity to synthesize long-chain PUFAs, making dietary intake and conversion critical.

Conclusions:

• Dietary n-3 and n-6 PUFA balance is crucial due to competing metabolic pathways and limited endogenous synthesis.
• Algae and genetically modified oil crops are promising alternative sources for long-chain PUFAs, addressing limitations in fish oil supply.
• Understanding PUFA metabolism and mediator function is key for developing novel therapeutic strategies for inflammatory conditions.